Baudson NM - Search Results

1

Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells.

Xia W, Gerard CM, Liu L, Baudson NM, Ory TL, Spector NL. Xia W, et al. Among authors: baudson nm. Oncogene. 2005 Sep 15;24(41):6213-21. doi: 10.1038/sj.onc.1208774. Oncogene. 2005. PMID: 16091755

2

Tumor mouse model confirms MAGE-A3 cancer immunotherapeutic as an efficient inducer of long-lasting anti-tumoral responses.

Gérard C, Baudson N, Ory T, Louahed J. Gérard C, et al. PLoS One. 2014 May 15;9(5):e94883. doi: 10.1371/journal.pone.0094883. eCollection 2014. PLoS One. 2014. PMID: 24830315 Free PMC article.

3

A Comprehensive Preclinical Model Evaluating the Recombinant PRAME Antigen Combined With the AS15 Immunostimulant to Fight Against PRAME-expressing Tumors.

Gérard C, Baudson N, Ory T, Segal L, Louahed J. Gérard C, et al. J Immunother. 2015 Oct;38(8):311-20. doi: 10.1097/CJI.0000000000000095. J Immunother. 2015. PMID: 26325375 Free PMC article.

4

Non-clinical safety evaluation of single and repeated intramuscular administrations of MAGE-A3 Cancer Immunotherapeutic in rabbits and cynomolgus monkeys.

Destexhe E, Grosdidier E, Baudson N, Forster R, Gerard C, Garçon N, Segal L. Destexhe E, et al. J Appl Toxicol. 2015 Jul;35(7):717-28. doi: 10.1002/jat.3025. Epub 2014 Sep 12. J Appl Toxicol. 2015. PMID: 25219328

5

Recombinant human papillomavirus type 16 E7 protein as a model antigen to study the vaccine potential in control and E7 transgenic mice.

Gérard CM, Baudson N, Kraemer K, Ledent C, Pardoll D, Bruck C. Gérard CM, et al. Clin Cancer Res. 2001 Mar;7(3 Suppl):838s-847s. Clin Cancer Res. 2001. PMID: 11300481

6

Therapeutic potential of protein and adjuvant vaccinations on tumour growth.

Gérard CM, Baudson N, Kraemer K, Bruck C, Garçon N, Paterson Y, Pan ZK, Pardoll D. Gérard CM, et al. Vaccine. 2001 Mar 21;19(17-19):2583-9. doi: 10.1016/s0264-410x(00)00486-2. Vaccine. 2001. PMID: 11257396

7

Nonclinical reproductive and developmental safety evaluation of the MAGE-A3 Cancer Immunotherapeutic, a therapeutic vaccine for cancer treatment.

Destexhe E, Stannard D, Wilby OK, Grosdidier E, Baudson N, Forster R, Gérard CM, Garçon N, Segal L. Destexhe E, et al. Reprod Toxicol. 2015 Jan;51:90-105. doi: 10.1016/j.reprotox.2014.12.009. Epub 2014 Dec 18. Reprod Toxicol. 2015. PMID: 25530039 Free article.

8

Loss of tumorigenicity and increased immunogenicity induced by interleukin-10 gene transfer in B16 melanoma cells.

Gérard CM, Bruyns C, Delvaux A, Baudson N, Dargent JL, Goldman M, Velu T. Gérard CM, et al. Hum Gene Ther. 1996 Jan;7(1):23-31. doi: 10.1089/hum.1996.7.1-23. Hum Gene Ther. 1996. PMID: 8825865

9

Non-clinical safety evaluation of repeated intramuscular administration of the AS15 immunostimulant combined with various antigens in rabbits and cynomolgus monkeys.

Garçon N, Silvano J, Kuper CF, Baudson N, Gérard C, Forster R, Segal L. Garçon N, et al. J Appl Toxicol. 2016 Feb;36(2):238-56. doi: 10.1002/jat.3167. Epub 2015 Jun 1. J Appl Toxicol. 2016. PMID: 26032931 Free PMC article. Clinical Trial.

10

Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma.

Cool V, Pirotte B, Gérard C, Dargent JL, Baudson N, Levivier M, Goldman S, Hildebrand J, Brotchi J, Velu T. Cool V, et al. Hum Gene Ther. 1996 Mar 20;7(5):627-35. doi: 10.1089/hum.1996.7.5-627. Hum Gene Ther. 1996. PMID: 8845388

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters